دورية أكاديمية

DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B.

التفاصيل البيبلوغرافية
العنوان: DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B.
المؤلفون: Yousefelahiyeh M; Department of Biological Sciences, California State University Los Angeles, Los Angeles, California, United States of America., Xu J; Department of Biological Sciences, California State University Los Angeles, Los Angeles, California, United States of America., Alvarado E; Department of Biological Sciences, California State University Los Angeles, Los Angeles, California, United States of America., Yu Y; Department of Biological Sciences, California State University Los Angeles, Los Angeles, California, United States of America., Salven D; Department of Biological Sciences, California State University Los Angeles, Los Angeles, California, United States of America., Nissen RM; Department of Biological Sciences, California State University Los Angeles, Los Angeles, California, United States of America.
المصدر: PloS one [PLoS One] 2018 Nov 29; Vol. 13 (11), pp. e0207779. Date of Electronic Publication: 2018 Nov 29 (Print Publication: 2018).
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural
اللغة: English
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
أسماء مطبوعة: Original Publication: San Francisco, CA : Public Library of Science
مواضيع طبية MeSH: Adaptor Proteins, Signal Transducing/*metabolism , Protein Serine-Threonine Kinases/*metabolism , Protein-Tyrosine Kinases/*metabolism, Adaptor Proteins, Signal Transducing/deficiency ; Adaptor Proteins, Signal Transducing/genetics ; Gene Expression Regulation ; Gene Knockdown Techniques ; HeLa Cells ; Humans ; Protein Serine-Threonine Kinases/genetics ; Protein-Tyrosine Kinases/genetics ; Transcription, Genetic ; Dyrk Kinases
مستخلص: Overexpression of the Dual-specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) gene contributes to the retardation, craniofacial anomalies, cognitive impairment, and learning and memory deficits associated with Down Syndrome (DS). DCAF7/HAN11/WDR68 (hereafter WDR68) binds DYRK1A and is required for craniofacial development. Accumulating evidence suggests DYRK1A-WDR68 complexes enable proper growth and patterning of multiple organ systems and suppress inappropriate cell growth/transformation by regulating the balance between proliferation and differentiation in multiple cellular contexts. Here we report, using engineered mouse C2C12 and human HeLa cell lines, that WDR68 is required for normal levels of DYRK1A. However, Wdr68 does not significantly regulate Dyrk1a mRNA expression levels and proteasome inhibition did not restore DYRK1A in cells lacking Wdr68 (Δwdr68 cells). Overexpression of WDR68 increased DYRK1A levels while overexpression of DYRK1A had no effect on WDR68 levels. We further report that WDR68 is similarly required for normal levels of the closely related DYRK1B kinase and that both DYRK1A and DYRK1B are essential for the transition from proliferation to differentiation in C2C12 cells. These findings reveal an additional role of WDR68 in DYRK1A-WDR68 and DYRK1B-WDR68 complexes.
Competing Interests: The authors have declared that no competing interests exist.
References: Hum Mol Genet. 2001 Sep 1;10(18):1915-23. (PMID: 11555628)
BMC Dev Biol. 2006 Jun 07;6:28. (PMID: 16759393)
Eur J Hum Genet. 2015 Apr;23(4):481-5. (PMID: 25026904)
Hum Mol Genet. 2016 Nov 15;25(22):4856-4869. (PMID: 28172997)
Cell. 2005 Jun 17;121(6):925-36. (PMID: 15960979)
Mol Cell. 2006 Sep 1;23(5):709-21. (PMID: 16949367)
Genes Cancer. 2010 Jan;1(1):40-9. (PMID: 20811583)
EMBO J. 2010 Nov 17;29(22):3750-61. (PMID: 20940704)
J Biol Chem. 2004 Jan 23;279(4):2490-8. (PMID: 14593110)
Genes Dev. 2011 Apr 15;25(8):801-13. (PMID: 21498570)
CNS Neurol Disord Drug Targets. 2014 Feb;13(1):26-33. (PMID: 24152332)
Exp Neurobiol. 2013 Dec;22(4):244-8. (PMID: 24465139)
Sci Rep. 2016 Jun 16;6:28241. (PMID: 27307198)
Mol Cell Biol. 1984 Aug;4(8):1449-53. (PMID: 6493226)
J Biol Chem. 1998 Oct 2;273(40):25893-902. (PMID: 9748265)
Biochim Biophys Acta. 2011 Oct;1813(10):1728-39. (PMID: 21777625)
Mol Cell. 2015 Feb 5;57(3):506-20. (PMID: 25620562)
Prog Nucleic Acid Res Mol Biol. 1999;62:1-17. (PMID: 9932450)
Am J Hum Genet. 2013 Dec 5;93(6):1118-25. (PMID: 24268655)
J Biol Chem. 2016 Oct 14;291(42):21893-21902. (PMID: 27573245)
Nat Commun. 2016 May 13;7:11491. (PMID: 27173435)
Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):10583-8. (PMID: 27601662)
PLoS One. 2013;8(1):e54363. (PMID: 23349862)
FEBS J. 2011 Jan;278(2):246-56. (PMID: 21126318)
J Virol. 2013 Sep;87(18):10348-55. (PMID: 23864635)
Hum Mol Genet. 2016 Jul 1;25(13):2862-2872. (PMID: 27033726)
J Biol Chem. 2014 Nov 28;289(48):33320-32. (PMID: 25342745)
Mol Cell Oncol. 2015 Jan 30;2(1):e970048. (PMID: 27308401)
Curr Opin Obstet Gynecol. 2014 Apr;26(2):92-103. (PMID: 24573065)
Biochem J. 2001 Nov 1;359(Pt 3):497-505. (PMID: 11672423)
Trends Biochem Sci. 2010 Oct;35(10):565-74. (PMID: 20451393)
Clin Genet. 2011 Mar;79(3):296-9. (PMID: 21294719)
J Virol. 2010 Mar;84(6):2719-31. (PMID: 20053746)
Biochemistry. 1992 Oct 6;31(39):9421-8. (PMID: 1356435)
Cell. 1983 Apr;32(4):1171-80. (PMID: 6839359)
J Clin Invest. 1997 Jul 1;100(1):197-203. (PMID: 9202072)
J Biol Chem. 2003 Oct 17;278(42):41347-54. (PMID: 12902328)
Eur J Neurosci. 2008 Mar;27(5):1061-74. (PMID: 18364031)
Sci Rep. 2017 Jul 25;7(1):6420. (PMID: 28743892)
Elife. 2017 Sep 08;6:. (PMID: 28884684)
Bioorg Med Chem Lett. 1999 Aug 2;9(15):2283-8. (PMID: 10465562)
Genetics. 2013 Nov;195(3):927-40. (PMID: 24026097)
Virology. 2013 Sep 1;443(2):313-20. (PMID: 23747199)
Mol Cell Biol. 2002 Sep;22(18):6636-47. (PMID: 12192061)
Birth Defects Res A Clin Mol Teratol. 2010 Dec;88(12):1008-16. (PMID: 20878909)
Nucleic Acids Res. 2018 Nov 30;46(21):11202-11213. (PMID: 30137413)
Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):E1224-E1233. (PMID: 28137862)
J Enzyme Inhib. 1990;3(3):195-201. (PMID: 2079636)
Genes Dev. 2011 Apr 15;25(8):814-30. (PMID: 21498571)
Am J Med Genet A. 2017 Nov;173(11):2861-2872. (PMID: 28941128)
Mol Cell. 2012 May 11;46(3):335-50. (PMID: 22521691)
Neuron. 1995 Feb;14(2):287-301. (PMID: 7857639)
Genome Res. 2011 Mar;21(3):447-55. (PMID: 21106904)
Genomics. 1999 May 1;57(3):407-18. (PMID: 10329007)
J Cell Biol. 1980 Jun;85(3):839-52. (PMID: 7190150)
J Biol Chem. 2015 Jun 12;290(24):15219-37. (PMID: 25918155)
BMC Med Genet. 2016 Feb 27;17:15. (PMID: 26922654)
Methods. 2001 Dec;25(4):402-8. (PMID: 11846609)
Am J Hum Genet. 2012 May 4;90(5):907-14. (PMID: 22560091)
Genesis. 2010 Jan;48(1):20-30. (PMID: 20014342)
Biochem Biophys Res Commun. 1993 Nov 15;196(3):1195-201. (PMID: 8250877)
Adv Protein Chem Struct Biol. 2016;105:127-71. (PMID: 27567487)
Am J Hum Genet. 2008 May;82(5):1165-70. (PMID: 18405873)
PLoS One. 2016 Nov 23;11(11):e0166984. (PMID: 27880803)
Dev Biol. 2002 Jun 15;246(2):259-73. (PMID: 12051815)
Hum Mol Genet. 1996 Sep;5(9):1305-10. (PMID: 8872470)
J Biol Chem. 2016 Dec 16;291(51):26399-26409. (PMID: 27807027)
Nature. 2005 Mar 17;434(7031):338-45. (PMID: 15735639)
Cell Cycle. 2014;13(13):2084-100. (PMID: 24806449)
Eur J Neurosci. 2003 Jun;17(11):2277-86. (PMID: 12814361)
Science. 2013 Feb 15;339(6121):819-23. (PMID: 23287718)
Nature. 2017 May 25;545(7655):505-509. (PMID: 28514442)
Cell Rep. 2013 Apr 25;3(4):1306-20. (PMID: 23602568)
FEBS J. 2009 Nov;276(21):6324-37. (PMID: 19796173)
J Virol. 2013 Jul;87(13):7781-6. (PMID: 23637414)
معلومات مُعتمدة: R15 DE022902 United States DE NIDCR NIH HHS
المشرفين على المادة: 0 (Adaptor Proteins, Signal Transducing)
0 (DCAF7 protein, human)
EC 2.7.10.1 (Protein-Tyrosine Kinases)
EC 2.7.11.1 (Protein Serine-Threonine Kinases)
تواريخ الأحداث: Date Created: 20181130 Date Completed: 20190422 Latest Revision: 20240404
رمز التحديث: 20240404
مُعرف محوري في PubMed: PMC6264848
DOI: 10.1371/journal.pone.0207779
PMID: 30496304
قاعدة البيانات: MEDLINE
الوصف
تدمد:1932-6203
DOI:10.1371/journal.pone.0207779